PREVALENSI PROTEINURIA DENGAN PEMERIKSAAN DIPSTIK URIN PADA PASIEN HIPERTENSI DI WILAYAH KERJA PUSKESMAS DAERAH TERPENCIL KABUPATEN ROTE NDAO
-
Berlan Paul E. Chandra(1*)
Dinas Kesehatan Rote Ndao
-
Septriati Haning(2)
Universitas Nusa Cendana
-
Yunita Siokh(3)
Universitas Nusa Cendana
-
Jefren Bulan(4)
Universitas Nusa Cendana
-
Widhyanto Adhy(5)
Universitas Nusa Cendana
(*) Corresponding Author
Abstract
Proteinuria merupakan salah satu penanda klinis penurunan fungsi ginjal dan merupakan marker yang paling sering ditemukan pada kasus hipertensi. Deteksi dini menggunakan metode dipstik test urin adalah metode yang paling dapat dilakukan khususnya pada pelayanan kesehatan tingkat pertama di daerah terpencil. Tujuan studi ini adalah untuk mengetahui prevalensiproteinuria pada pasien hipertensi di puskesmas daerah terpencil Kabupaten Rote Ndao dengan laboratorium sederhana dipstik urin. Penelitian ini merupakan penelitian deskriptif dengan metode potong lintang, sebanyak 70 subyek dengan riwayat hipertensi dilakukan pemeriksaan proteinurin dan wawancara faktor resiko kemudian dianalisa dalam studi ini. Hasil analisis data menunjukan 40% subyek memiliki proteinuria dengan tingkatan +1 sampai dengan +3. Faktor-faktor yang dianggap mempengaruhi proteinuria secara statistik meliputi lama hipertensi, derajat hipertensi, status gizi, riwayat diabetes, konsumsi garam, dan riwayat penyakit keluarga.
Downloads
References
2. Anderson, Amanda Hyre. "Screening for proteinuria: a tool for predicting rapid declines in kidney function?." (2011): 1580-1583.
3. Alicic, Radica Z., Michele T. Rooney, and Katherine R. Tuttle. "Diabetic kidney disease: challenges, progress, and possibilities." Clinical Journal of the American Society of Nephrology 12.12 (2017): 2032-2045.
4. American Diabetes Association. "Standards of medical care in diabetes—2019 abridged for primary care providers." Clinical diabetes: a publication of the American Diabetes Association 37.1 (2019): 11.
5. Hasil Utama Riskesdas 2018. Kementrian Kesehatan Republik Indonesia, Badan Penelitian dan Pengembangan Kesehatan. Jakarta. 2018
6. Pugh, Dan, Peter J. Gallacher, and Neeraj Dhaun. "Correction to: Management of Hypertension in Chronic Kidney Disease." Drugs (2020): 1-1.
7. Mahajan, Rajiv. "Joint National Committee 8 report: How it differ from JNC 7." International Journal of Applied and Basic Medical Research 4.2 (2014): 61.
8. Thirumavalavan, S., S. M. Balaji, and R. Vijaya Kumar. "Diagnostic efficacy of urine dipstick in detecting chronic kidney disease." (2019).
9. Park, Ji In, et al. "Comparison of urine dipstick and albumin: creatinine ratio for chronic kidney disease screening: A population-based study." PloS one 12.2 (2017): e0171106.
10. Lim, Dongmin, et al. "Diagnostic accuracy of urine dipstick for proteinuria in older outpatients." Kidney research and clinical practice 33.4 (2014): 199-203.
11. GAZALI, MEGAWATI. "KADAR CYSTATIN-C SERUM PADA PENDERITA DIABETES MELITUS TANPA PROTEINURIA DENGAN KADAR KREATININ NORMAL." digilib. UNHAS. Makassar 2017
12. Jefferson, J. A., S. J. Shankland, and R. H. Pichler. "Proteinuria in diabetic kidney disease: a mechanistic viewpoint." Kidney international 74.1 (2008): 22-36.
13. Ekblom-Bak, Elin, et al. "The importance of non-exercise physical activity for cardiovascular health and longevity." British journal of sports medicine 48.3 (2014): 233-238.
14. Damtie S, Biadgo B, Baynes HW, et al. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018;28(6):691-700. doi:10.4314/ejhs.v28i6.3
15. Satko, Scott & Freedman, Barry. (2004). The importance of family history on the development of renal disease. Current opinion in nephrology and hypertension. 13. 337-41. 10.1097/00041552-200405000-00012.
Copyright (c) 2020 Cendana Medical Journal (CMJ)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.
